Home/Pipeline/ELIOS System

ELIOS System

Mild-to-Moderate Primary Open-Angle Glaucoma (concurrent with cataract surgery)

ClinicalActive

Key Facts

Indication
Mild-to-Moderate Primary Open-Angle Glaucoma (concurrent with cataract surgery)
Phase
Clinical
Status
Active
Company

About Elios Vision

Elios Vision is a clinical-stage medical device company pioneering a novel, laser-based approach to glaucoma treatment. Its ELIOS system is a minimally invasive glaucoma surgery (MIGS) device that uses a cold excimer laser to precisely ablate tissue and restore the eye's natural drainage pathway, with the key advantage of being performed simultaneously with cataract surgery. The company is targeting the large and growing global market for glaucoma interventions, aiming to offer a safer and more effective alternative to traditional surgeries and standalone MIGS devices. As a private firm, Elios is likely advancing through clinical validation and regulatory pathways towards commercialization.

View full company profile

Therapeutic Areas